Drug Discov Today 2002 Oct 15;7(20):1023-4
Sutherland S.
By flipping a peptide upside down and inside out, an Ohio State University (http://medicine.osu.edu) researcher has created a molecule that appears to turn off a T-cell stimulant in autoimmune disease, while largely leaving the T-cell suppressor alone.
The Director of Biomedical Research Services for the National Multiple Sclerosis Society (http://www.nmss.org), Patricia Olooney, calls it, 'the next stage of treatment for autoimmune disease.'